logo-supreme-whiteSupreme Pharmaceuticals, Inc, alternatively known as Supreme Pharma and Bioscience, is a former mining company and current biomedicine company in Canada. Its particularly delves on medical marijuana, with a greenhouse in Ontario and preparations underway for online product sales.

The company’s history goes way back to 1979, when it was founded. It went through various businesses and names such as Sonar Energy Company, US Platinum, Inc, and Universal Energy Corp. In 2007, it became Supreme Resources, Ltd, a junior mineral exploration company operating in BC for base and precious metals. Finally, in March 2014, the company pursued its new direction and became Supreme Pharmaceuticals, Inc.

Supreme Pharma is now on the Canadian Stock Exchange under the symbol SL, and on the US OTC markets under the symbol SPRWF. Its market cap is around USD 22.91 M.

The flagship of Supreme Pharma is the Supreme Greenhouse located in Kincardine, Ontario. Covering a total of 342,000 square feet, the facility will allot 280,000 square feet for growing cannabis and over 6,000 square feet for research and development. Supreme emphasizes that unlike many marijuana grow operations, which cultivate the plant indoors, the Supreme Greenhouse will use natural sunlight and supplement it with state-of-the-art equipment.

The company is now preparing to sell its marijuana products online, with an online shop and a customer discount program named CanAssist.

Supreme Pharma’s grow operations started with is acquisition of Advanced Medical Marijuana Canada (AMMCan). Preapproved by Health Canada, AMMCan may produce and distribute up to 24,000 kilograms of marijuana annually. After it became Supreme Pharma’s wholly owned subsidiary, AMMCan is now called Supreme Medical Marijuana (AMMCan Supreme).

Supreme Pharmaceuticals, Inc is led by Chairman, President, and CEO David Stadnyk, Executive VP Brayden R. Sutton, and Production Advisor Thaddeus Conrad. AMMCan executives meanwhile include CEO Peter M. Herburger, Director of Operations John Fowler, and Medical Director Dr. Kenneth Adams.

Yahoo! Finance: SPRWF News

Latest Financial News for SPRWF

Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of BlissCo Cannabis Corp. (Other OTC: HSTRF) on Behalf of BlissCo Shareholders and Encourages BlissCo Investors to Contact the Firm

NEW YORK, May 21, 2019 -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of BlissCo Cannabis Corp. (Other OTC: HSTRF) on.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Blissco Cannabis Corp. to The Supreme Cannabis Company, Inc. is Fair to Shareholders

NEW YORK, May 20, 2019 -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Blissco Cannabis Corp. (“Blissco”.

Aurora maps its future as New Jersey gets set to put cannabis legalization to the vote

Aurora Cannabis Inc. shares were in focus again Thursday, as investors continued to digest weaker-than-expected earnings and the company’s plans to grow its business.

Cannastocks2019 Investor Conference & Webinar Now Available for On-Demand Viewing

Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations NEW YORK , May 17, 2019 /PRNewswire/ -- Virtual Investor Conferences, ...

Supreme Cannabis Acquires Blissco Cannabis In $36.6M Deal

Under the terms of the agreement, shareholders of Blissco will be offered 0.24 shares of Supreme Cannabis Company for each share they hold. Blissco, which positions itself as a premium wellness cannabis brand, will join Supreme Cannabis’ portfolio of brands and will operate as Supreme’s health and wellness business. The acquisition will give Supreme Cannabis Company access to Blissco’s 18,000 square foot production facility in Langley, British Columbia.